Abstract
We explore the effect of co-opted directors on R&D investments. Co-opted directors are those appointed after the incumbent CEO assumes office. Because a co-opted board represents a weakened governance mechanism that diminishes the probability of executive removal, managers are less likely to be removed and are more motivated to make long-term investments. Our evidence shows that board co-option leads to significantly higher R&D investments. To draw a causal inference, we execute a quasi-natural experiment using an exogenous regulatory shock from the Sarbanes-Oxley Act (SOX). Our results reveal that the effect of board co-option on R&D is more likely causal.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 285-289 |
| Number of pages | 5 |
| Journal | Finance Research Letters |
| Volume | 17 |
| DOIs | |
| State | Published - May 1 2016 |
All Science Journal Classification (ASJC) codes
- Finance
Fingerprint
Dive into the research topics of 'Do co-opted directors mitigate managerial myopia? Evidence from R&D investments'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver